Maximus (MMS) director reports 693.707 dividend-equivalent shares, total 315,939.624 owned
Rhea-AI Filing Summary
Maximus, Inc. director Raymond B. Ruddy reported an automatic equity-related transaction involving the company’s common stock. On 12/01/2025, he acquired 693.707 shares of Maximus common stock at a price of $0. These were credited as dividend equivalent rights tied to previously awarded restricted stock units, meaning each right is economically equivalent to one share of Maximus common stock and vests proportionately with the underlying RSUs.
Following this transaction, Ruddy beneficially owned a total of 315,939.624 shares of Maximus common stock in direct form. The filing indicates this was a routine update of his holdings and does not involve any sale of shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 693.707 | $0.00 | $0.00 |
Footnotes (1)
- F1. Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of Maximus common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Maximus (MMS) disclose in this Form 4?
Maximus disclosed that director Raymond B. Ruddy acquired 693.707 shares of common stock on 12/01/2025 at a price of $0, reported as dividend equivalent rights tied to existing restricted stock units.
Who signed the Maximus (MMS) Form 4 on behalf of the reporting person?
The Form 4 was signed by John T. Martinez as Attorney-In-Fact for Raymond B. Ruddy on 12/02/2025.